Step 2: The Bridge Therapies As you lower the dose of Semaglutide or Tirzepatide, we often introduce non-GLP-1 therapies to support your metabolism
Although some studies have raised concerns about pancreatitis and thyroid-related risks, the current evidence does not conclusively establish causality
cREB, cAMP-response element binding protein
The current medical consensus, reflected in obesity medicine guidelines from organizations such as the American Gastroenterological Association and Obesity Medicine Association, treats obesity as a chronic disease requiring long-term pharmacological management in most cases, similar to hypertension or hyperlipidemia
Resources : Nurjhan N, Bucci A, Perriello G, et al
Endocrinology 150, 53265333